IL-23 Contributes to Campylobacter jejuni-Induced Intestinal Pathology via Promoting IL-17 and IFNγ Responses by Innate Lymphoid Cells

Human pathogen Campylobacter jejuni is a significant risk factor for the development of long-term intestinal dysfunction although the cellular and molecular mechanisms remain scantily defined. IL-23 is an emerging therapeutic target for the treatment of inflammatory intestinal diseases, however its...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Xi, Korchagina, Anna A., Shein, Sergey A., Muraoka, Wayne T., Koroleva, Ekaterina, Tumanov, Alexei V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815532/
https://www.ncbi.nlm.nih.gov/pubmed/33488580
http://dx.doi.org/10.3389/fimmu.2020.579615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815532/
https://www.ncbi.nlm.nih.gov/pubmed/33488580
http://dx.doi.org/10.3389/fimmu.2020.579615

Ejemplares similares